Thus, the present evidence for a CDK-independent role of cyclin D1 in driving mammary tumorigenesis may be especially relevant to human breast cancer, particularly the large subset with clonally selected cyclin D1 gene amplification and potentially the multiple other types of human tumors similarly driven by cyclin D1 amplification or rearrangement [1]. Here, CCND1 is linked to breast carcinoma.